Placing

 

TIDMHML 
 
RNS Number : 1489I 
Henderson Morley PLC 
05 March 2010 
 

                                                                    5 March 2010 
                              HENDERSON MORLEY PLC 
                      ("Henderson Morley" or the "Company") 
                                   (AIM: HML) 
                                    PLACING 
Henderson Morley plc, the Aim quoted biotechnology company, announces that it 
has raised GBP444,597 before expenses, via a placing ('the Placing') by 
Rivington Street Corporate Finance to institutional and other investors of 
246,998,333 million New Ordinary Shares of 0.125 pence in the Company at a price 
of 0.18 pence per share. 
Andrew Knight and Dr Ian Pardoe, Directors of the Company, have each undertaken 
to subscribe GBP60,000 and GBP40,000 for 33,333,333 and 22,222,222 New Ordinary 
Shares respectively as part of the Placing. The Directors, other than Messrs 
Knight and Pardoe, having consulted with the Company's nominated adviser, Brewin 
Dolphin, believe that the terms of this transaction are fair and reasonable 
insofar as shareholders are concerned. 
The funds raised through the Placing will be used for working capital whilst 
further pre sale due diligence continues on the ICVT platform and whilst the 
Company works towards its stated strategy of becoming a pure play vaccine 
company by 2011. 
The Placing is conditional on the admission of the New Ordinary Shares to 
trading on AIM. 224,776,111 New Ordinary Shares have today been allotted, and 
application has been made for these shares to be admitted to AIM. Trading in the 
new shares is expected to commence on 10 March 2010. It is expected that the 
further 22,222,222 New Ordinary Shares (11,111,111 to Mr.  A Knight and 
11,111,111 to Dr I Pardoe) will be allotted by 20 April 2010, at which time a 
further announcement will be made. 
 
Following Admission of the 224,776,111 shares allotted today, Mr. A Knight and 
Dr I Pardoe will own 159,640,986 and 110,338,862 shares respectively, 
representing 11.57% and 8.00% respectively of the Company's enlarged issued 
share capital of 1,379,498,574 shares in issue. 
                                      -END- 
 Enquires 
HENDERSON MORLEY PLC 
          0121 442 4600 
Andrew Knight, Chairman 
RIVINGTON STREET CORPORATE FINANCE                                       0207 
562 3380 
Dru Edmonstone 
BREWIN DOLPHIN INVESTMENT BANKING                                        0113 
241 0126 
Neil Baldwin 
BISHOPSGATECOMMUNICATIONS LTD 
0207 562 3350 
Maxine Barnes 
 Gemma O'Hara 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 STRMMGGFGKZGGZM